United BioPharma Inc (6471) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

United BioPharma Inc (United BioPharma) is a pharmaceutical company. The company develops, manufactures, and markets monoclonal antibody (mAb) products and biosimilar antibodies. Its molecules product pipeline includes UB-421, a monoclonal antibody for AIDS treatment; and UB-621, an anti-herpes simplex virus (HSV) monoclonal antibody. United BioPharma offers UB-221, an anti-allergic monoclonal antibody; and UB-721, a biosimilar antibody for anti-autoimmune disease. The company also provides UB-923, UB-925, UB-923, UB-921 and UB-922 for malignant tumour. It has operations throughout the US and China. United BioPharma is headquartered in Hukou, Taiwan.

United BioPharma Inc (6471) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
United BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
United BioPharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
United BioPharma Enters into Licensing Agreement with Academia Sinica for Cancer 10
United BioPharma Enters into Licensing Agreement with Academia Sinica 11
Equity Offering 12
United BioPharma to Raise USD26.8 Million in Rights Offering of Shares 12
United BioPharma to Raise USD1.8 Million in Rights Offering of Shares 13
United BioPharma Raises USD15.6 Million in Public Offering of Shares 14
United BioPharma Raises USD27.8 Million in the Private Placement of Shares 15
United BioPharma Inc - Key Competitors 16
United BioPharma Inc - Key Employees 17
United BioPharma Inc - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Apr 04, 2017: United BioPharma holds an inauguration ceremony marking the opening of its new manufacturing plant 19
Other Significant Developments 20
Mar 05, 2018: UBP Construction Plan to start on new facility for biopharmaceutical manufacturing in China 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables


United BioPharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
United BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
United BioPharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
United BioPharma Enters into Licensing Agreement with Academia Sinica for Cancer 10
United BioPharma Enters into Licensing Agreement with Academia Sinica 11
United BioPharma to Raise USD26.8 Million in Rights Offering of Shares 12
United BioPharma to Raise USD1.8 Million in Rights Offering of Shares 13
United BioPharma Raises USD15.6 Million in Public Offering of Shares 14
United BioPharma Raises USD27.8 Million in the Private Placement of Shares 15
United BioPharma Inc, Key Competitors 16
United BioPharma Inc, Key Employees 17
United BioPharma Inc, Other Locations 18

List Of Figures


United BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
United BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

United BioPharma Inc (6471) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

United BioPharma Inc (United BioPharma) is a pharmaceutical company. The company develops, manufactures, and markets monoclonal antibody (mAb) products and biosimilar antibodies. Its molecules product pipeline includes UB-421, a monoclonal

USD 250 View Report

Movies and Entertainment in the United Kingdom

Movies & Entertainment in the United KingdomMovies & Entertainment in the United Kingdom industry profile provides top-line qualitative and quantitative information including: market size (value 2013-17, and forecast to

USD 350 View Report

Principia Biopharma Inc (PRNB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. The company, through its proprietary

USD 250 View Report

Sutro Biopharma Inc (STRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADCs), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways.

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available